How Much Weight Can You Actually Lose on GLP-1s? (Realistic Timelines)

Physician-run telehealth — TN · FL · GA · OH · WA. One doctor reviews every case. No queue, no chatbot.

How Much Weight Can You Actually Lose on GLP-1s? (Realistic Timelines)

Paul Miranda, MD
Board-Certified in Family Medicine · Emergency Physician · Obesity Medicine Association member

I’m an emergency and Family Medicine physician in Chattanooga, Tennessee, and founder of Summit Metabolic Health. I read every patient chart personally. This article reports on a topic patients keep asking about — it is education, not an endorsement.

Medically reviewed by Paul Miranda, MD

If you live in Chattanooga or Signal Mountain and you’re considering a GLP-1 medication for weight loss, you’ve probably seen the dramatic before-and-after photos. What you’ve likely not seen is an honest, physician-led explanation of what the numbers actually look like, how long it takes, and why results differ from person to person.

At Summit Metabolic Health, Dr. Paul Miranda, MD, MBA reviews every patient’s chart personally. Here’s the straight answer to the question we hear most: how much weight can you really lose? (If you’re still deciding whether this class of medication is even a fit, our guide on who qualifies for GLP-1 weight loss is a good place to start.)

These medications are among the most studied weight-loss treatments ever brought to market. Here’s what the research found (these are group averages from clinical trials — individual results vary):

Semaglutide: about 14.9% mean body-weight reduction at 68 weeks (STEP 1, NEJM 2021). The newer higher-dose 7.2 mg formulation reached roughly 20.7% at 72 weeks (STEP UP). – Tirzepatide: about 20.9% at the 15 mg dose over 72 weeks (SURMOUNT-1, NEJM 2022). – Head-to-head: tirzepatide produced about 20.2% loss versus semaglutide’s 13.7% at 72 weeks (SURMOUNT-5, NEJM 2025).

To put that in real terms: a 250-pound person averaging 15% loss would be down roughly 37 pounds; at 20%, about 50 pounds. Again — these are averages, not promises.

Most people respond, but not identically

In the semaglutide STEP 1 trial, 86% of participants lost at least 5% of their body weight, 69% lost at least 10%, and 50% lost at least 15%. That’s why a one-size-fits-all telehealth script doesn’t make sense — your body’s response is your own.

If you have type 2 diabetes, expect somewhat less: roughly 10% on semaglutide (STEP 2) and about 15% on tirzepatide (SURMOUNT-2). This blunting is well documented, and it’s exactly the kind of nuance a physician should set expectations around before you start.

Weight loss on a GLP-1 is a marathon, not a sprint:

Weeks 1–16: Dose is escalated gradually (typically over 16–20 weeks). This slow ramp is intentional — it minimizes side effects. You’ll see some early loss, but the dose isn’t yet at its full effect. – Months 4–12: This is where most of the loss accrues, month over month. – Around 12 months: Weight loss tends to plateau, and with continued therapy it’s maintained out to two years (STEP 5).

Anyone promising you 30 pounds in a month is selling hype, not medicine. For a week-by-week sense of what that early ramp-up actually feels like, see our guide to your first month on a GLP-1.

Summit uses custom-dosed compounded GLP-1 (semaglutide or tirzepatide), which lets Dr. Miranda titrate to your tolerance — gentler when you need it, more aggressive when you’re ready. The program is also built to get cheaper as you get healthier, with a physician-directed maintenance and exit strategy rather than an open-ended subscription.

We serve patients across Tennessee, Florida, Washington, Ohio, and Georgia — in person at our Chattanooga office and via telehealth — so whether you’re on Signal Mountain or across the state line, care is accessible. Still weighing a weekly injection against a daily pill? Our comparison of injection vs. pill GLP-1 options can help you decide which route fits your life.

The best way to set realistic expectations is a conversation with a physician who will actually look at your history.

Book a free 20-minute consultation with Summit Metabolic Health. No software questionnaire, no nurse queue — Dr. Miranda reviews your chart himself. Or browse more physician-led guides on our blog while you weigh your options.


This article is for educational purposes only and is not medical advice. Efficacy figures are group averages from clinical trials; individual results vary. Speak with a qualified physician about your specific situation. Summit Metabolic Health · 200 W MLK Blvd Ste 1000, Chattanooga TN 37402 · (423) 407-7837 · info@summitmetabolic.health · summitmetabolichealth.com

Summit Metabolic Health

Physician-run GLP-1 weight loss and hormone care — the only program built to get you off medication, not keep you on it.

Telehealth only · Licensed in TN · FL · GA · OH · WA
200 M.L.K. Blvd, Suite 1000, Chattanooga, TN 37402
(423) 407-7837 · pmiranda@summitmetabolic.health

LegitScript certified — verify approval for summitmetabolichealth.com
© 2026 Summit Metabolic Health. All rights reserved.

Summit Metabolic Health provides telehealth services to patients located in Tennessee, Florida, Georgia, Ohio and Washington. Content on this site is for general information and is not a substitute for individualized medical advice. Medication is prescribed only after a physician evaluation determines it is appropriate, and is dispensed and billed separately through an independent, licensed 503A compounding pharmacy. Individual results vary. Compounded medications are prepared for an individual patient by prescription and are not approved or evaluated by the FDA for safety, effectiveness, or quality. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S; Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Summit Metabolic Health is not affiliated with Novo Nordisk or Eli Lilly, and compounded semaglutide and tirzepatide are not those branded products.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *